Device Trial Radar · NCT00769808
Technolas 217z Laser With Zyoptix Aspheric Algorithm Used for the LASIK Treatment of Myopia and Myopic Astigmatism.
Last checked: Nov 20, 2026Latest source record: Sep 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Aug 2008
Primary completion
Mar 2010
Study completion Mar 2010
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 9, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the Bausch \& Lomb Technolas 217z laser with the investigational Zyoptix Aspheric Algorithm when used for LASIK treatment of myopia and myopic astigmatism.
Conditions
- Myopia
- Astigmatism
Interventions
Bausch & Lomb 217z Excimer LaserDevice
LASIK correction of myopia and myopic astigmatism
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Eyes With Uncorrected High Contrast Distance Visual Acuity of 20/40 or BetterTime frame: 3 months
- Percentage of Eyes With Manifest Subjective Refraction (MRSE) Within ± 1.00 Diopter (D) and 0.50 D of EmmetropiaTime frame: 3 months
- Preservation of Manifest Best Corrected High Contrast Distance Visual AcuityTime frame: Baseline, 3 months
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Lasik MD, 130 King Street
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.